2021 Q2 Form 10-Q Financial Statement

#000002617221000027 Filed on May 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q1
Revenue $6.092B $5.011B
YoY Change 58.15% -16.54%
Cost Of Revenue $4.606B $3.717B
YoY Change 55.5% -16.88%
Gross Profit $1.486B $1.294B
YoY Change 66.97% -15.54%
Gross Profit Margin 24.39% 25.82%
Selling, General & Admin $574.0M $546.0M
YoY Change 22.13% -7.93%
% of Gross Profit 38.63% 42.19%
Research & Development $260.0M $238.0M
YoY Change 37.57% 0.42%
% of Gross Profit 17.5% 18.39%
Depreciation & Amortization $170.0M $168.0M
YoY Change 3.03% 7.01%
% of Gross Profit 11.44% 12.98%
Operating Expenses $834.0M $784.0M
YoY Change 26.56% -5.54%
Operating Profit $810.0M $634.0M
YoY Change 141.07% -20.65%
Interest Expense $28.00M $23.00M
YoY Change 21.74% -28.13%
% of Operating Profit 3.46% 3.63%
Other Income/Expense, Net $1.000M $44.00M
YoY Change -97.96% -33.33%
Pretax Income $783.0M $655.0M
YoY Change 116.3% -22.49%
Income Tax $172.0M $127.0M
% Of Pretax Income 21.97% 19.39%
Net Earnings $611.0M $528.0M
YoY Change 127.14% -21.08%
Net Earnings / Revenue 10.03% 10.54%
Basic Earnings Per Share $4.10 $3.42
Diluted Earnings Per Share $4.07 $3.41
COMMON SHARES
Basic Shares Outstanding 147.0M shares 149.3M shares
Diluted Shares Outstanding 148.3M shares 149.7M shares

Balance Sheet

Concept 2021 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.355B $2.030B
YoY Change 59.46% 28.97%
Cash & Equivalents $2.958B $1.691B
Short-Term Investments $397.0M $339.0M
Other Short-Term Assets $805.0M $676.0M
YoY Change 26.97% 12.85%
Inventory $3.753B $3.579B
Prepaid Expenses
Receivables $4.209B $3.505B
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.12B $9.790B
YoY Change 23.27% -2.98%
LONG-TERM ASSETS
Property, Plant & Equipment $4.196B $4.128B
YoY Change 3.17% 1.52%
Goodwill $1.290B $1.283B
YoY Change 0.47% 14.04%
Intangibles $964.0M $965.0M
YoY Change -5.21% 7.82%
Long-Term Investments $1.592B $1.304B
YoY Change 16.89% 0.08%
Other Assets $1.713B $1.617B
YoY Change -2.23% 13.31%
Total Long-Term Assets $10.84B $10.29B
YoY Change 3.44% 5.44%
TOTAL ASSETS
Total Short-Term Assets $12.12B $9.790B
Total Long-Term Assets $10.84B $10.29B
Total Assets $22.96B $20.08B
YoY Change 13.04% 1.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.279B $2.648B
YoY Change 43.75% -12.26%
Accrued Expenses $1.121B $971.0M
YoY Change 21.85% 1.36%
Deferred Revenue $773.0M $527.0M
YoY Change 47.8%
Short-Term Debt $410.0M $1.738B
YoY Change -80.81% 123.11%
Long-Term Debt Due $61.00M $33.00M
YoY Change -7.58% -10.81%
Total Short-Term Liabilities $6.660B $6.982B
YoY Change -3.7% 8.64%
LONG-TERM LIABILITIES
Long-Term Debt $3.620B $1.580B
YoY Change 120.87% -1.56%
Other Long-Term Liabilities $1.510B $1.431B
YoY Change -4.79% 20.45%
Total Long-Term Liabilities $1.510B $1.431B
YoY Change -4.79% 20.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.660B $6.982B
Total Long-Term Liabilities $1.510B $1.431B
Total Liabilities $13.93B $12.06B
YoY Change 14.34% 8.45%
SHAREHOLDERS EQUITY
Retained Earnings $15.83B $14.73B
YoY Change 6.85% 9.9%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.172B $7.744B
YoY Change 5.73% 26.72%
Treasury Stock Shares 76.20M shares 74.90M shares
Shareholders Equity $8.109B $7.068B
YoY Change
Total Liabilities & Shareholders Equity $22.96B $20.08B
YoY Change 13.04% 1.16%

Cashflow Statement

Concept 2021 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $611.0M $528.0M
YoY Change 127.14% -21.08%
Depreciation, Depletion And Amortization $170.0M $168.0M
YoY Change 3.03% 7.01%
Cash From Operating Activities $339.0M $379.0M
YoY Change -1640.91% -8.01%
INVESTING ACTIVITIES
Capital Expenditures $87.00M $75.00M
YoY Change -196.67% -31.19%
Acquisitions $0.00
YoY Change
Other Investing Activities -$19.00M -$6.000M
YoY Change -57.78% -80.65%
Cash From Investing Activities -$25.00M -$99.00M
YoY Change -81.48% 39.44%
FINANCING ACTIVITIES
Cash Dividend Paid $197.0M $195.0M
YoY Change 8.94%
Common Stock Issuance & Retirement, Net $400.0M $537.0M
YoY Change 437.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$745.0M $234.0M
YoY Change -429.65% -167.44%
NET CHANGE
Cash From Operating Activities $339.0M $379.0M
Cash From Investing Activities -$25.00M -$99.00M
Cash From Financing Activities -$745.0M $234.0M
Net Change In Cash -$443.0M $562.0M
YoY Change -742.03% 2148.0%
FREE CASH FLOW
Cash From Operating Activities $339.0M $379.0M
Capital Expenditures $87.00M $75.00M
Free Cash Flow $252.0M $304.0M
YoY Change 270.59% 0.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000026172
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-04
CY2021Q2 dei Entity File Number
EntityFileNumber
1-4949
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
CUMMINS INC.
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IN
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-0257090
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
500 Jackson Street
CY2021Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Box 3005
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Columbus
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
47202-3005
CY2021Q2 dei City Area Code
CityAreaCode
812
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
377-5000
CY2021Q2 dei Security12b Title
Security12bTitle
Common stock, $2.50 par value
CY2021Q2 dei Trading Symbol
TradingSymbol
CMI
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 us-gaap Profit Loss
ProfitLoss
528000000 USD
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
146202578 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2021Q2 us-gaap Revenues
Revenues
6092000000 USD
CY2020Q1 us-gaap Revenues
Revenues
5011000000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
4606000000 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
3717000000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
1486000000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
1294000000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
574000000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
546000000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
260000000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
238000000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
166000000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
129000000 USD
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-8000000 USD
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-5000000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
810000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
634000000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
28000000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
23000000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
44000000 USD
CY2021Q2 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
783000000 USD
CY2020Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
655000000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
172000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
127000000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
611000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
528000000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17000000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
603000000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
511000000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.10
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.42
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.07
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.41
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147000000.0 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149300000 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1300000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
400000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148300000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149700000 shares
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
478000000 USD
CY2020Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
257000000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
611000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-29000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-2000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-56000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-162000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
72000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-79000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-239000000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
656000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
289000000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
648000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
289000000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2958000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3401000000 USD
CY2021Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
397000000 USD
CY2020Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
461000000 USD
CY2021Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
3355000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
3862000000 USD
CY2021Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
3698000000 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3440000000 USD
CY2021Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
511000000 USD
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
380000000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
3753000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
3425000000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
805000000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
790000000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
12122000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
11897000000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9044000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9011000000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4848000000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4756000000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4196000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4255000000 USD
CY2021Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1592000000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1441000000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
1290000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1293000000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
964000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
963000000 USD
CY2021Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
1085000000 USD
CY2020Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
1042000000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1713000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1733000000 USD
CY2021Q2 us-gaap Assets
Assets
22962000000 USD
CY2020Q4 us-gaap Assets
Assets
22624000000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3279000000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2820000000 USD
CY2021Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
93000000 USD
CY2020Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
169000000 USD
CY2021Q2 us-gaap Commercial Paper
CommercialPaper
317000000 USD
CY2020Q4 us-gaap Commercial Paper
CommercialPaper
323000000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
393000000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
484000000 USD
CY2021Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
623000000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
674000000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
773000000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
691000000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1121000000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1112000000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
61000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
62000000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6660000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6335000000 USD
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3620000000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3610000000 USD
CY2021Q2 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
621000000 USD
CY2020Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
630000000 USD
CY2021Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
692000000 USD
CY2020Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
672000000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
828000000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
840000000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1510000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1548000000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
13931000000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
13635000000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
222400000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
222400000 shares
CY2021Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
2393000000 USD
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
2404000000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15825000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15419000000 USD
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
76200000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
74800000 shares
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8172000000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
7779000000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1937000000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1982000000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
8109000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
8062000000 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
922000000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
927000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9031000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8989000000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22962000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22624000000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
611000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
528000000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
170000000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
168000000 USD
CY2021Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
8000000 USD
CY2020Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-11000000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
136000000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
78000000 USD
CY2021Q2 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
20000000 USD
CY2020Q1 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
27000000 USD
CY2021Q2 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
51000000 USD
CY2020Q1 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
60000000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
8000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4000000 USD
CY2021Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
0 USD
CY2020Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
48000000 USD
CY2021Q2 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
-32000000 USD
CY2020Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
17000000 USD
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1000000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
374000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-107000000 USD
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
336000000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
171000000 USD
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
24000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-79000000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
465000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
171000000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-24000000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-321000000 USD
CY2021Q2 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
0 USD
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-28000000 USD
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
31000000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
30000000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
339000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
379000000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
75000000 USD
CY2021Q2 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
11000000 USD
CY2020Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
8000000 USD
CY2021Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
24000000 USD
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
7000000 USD
CY2021Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
143000000 USD
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
116000000 USD
CY2021Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
207000000 USD
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
95000000 USD
CY2021Q2 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-14000000 USD
CY2020Q1 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-6000000 USD
CY2021Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-19000000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-6000000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99000000 USD
CY2021Q2 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-6000000 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
957000000 USD
CY2021Q2 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
16000000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
10000000 USD
CY2021Q2 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In More Than Three Months
ProceedsFromRepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
-102000000 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In More Than Three Months
ProceedsFromRepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
25000000 USD
CY2021Q2 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
13000000 USD
CY2020Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
13000000 USD
CY2021Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
197000000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
195000000 USD
CY2021Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
418000000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
550000000 USD
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18000000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13000000 USD
CY2021Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11000000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
7000000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-745000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
234000000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-12000000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
48000000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-443000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
562000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3401000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1129000000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2958000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1691000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8989000000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
611000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45000000 USD
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
418000000 USD
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.35
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
197000000 USD
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
13000000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
18000000 USD
CY2021Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
4000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9031000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8465000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
528000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-239000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
18000000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
550000000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.311
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
195000000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
13000000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
13000000 USD
CY2020Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
14000000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8018000000 USD
CY2021Q2 us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1. NATURE OF OPERATIONS AND BASIS OF PRESENTATION</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cummins Inc. (“Cummins,” “we,” “our” or “us”) was founded in 1919 as Cummins Engine Company, a corporation in Columbus, Indiana, and one of the first diesel engine manufacturers. In 2001, we changed our name to Cummins Inc. We are a global power leader that designs, manufactures, distributes and services diesel, natural gas, electric and hybrid powertrains and powertrain-related components including filtration, aftertreatment, turbochargers, fuel systems, controls systems, air handling systems, automated transmissions, electric power generation systems, batteries, electrified power systems, hydrogen production and fuel cell products. We sell our products to original equipment manufacturers (OEMs), distributors, dealers and other customers worldwide. We serve our customers through a network of over 500 wholly-owned, joint venture and independent distributor locations and over 9,000 Cummins certified dealer locations with service to approximately 190 countries and territories.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interim Condensed Financial Statements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reflect all adjustments which, in the opinion of management, are necessary for a fair statement of the results of operations, financial position and cash flows. All such adjustments are of a normal recurring nature. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were prepared in accordance with accounting principles in the United States of America (GAAP) pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial information. Certain information and footnote disclosures normally included in annual financial statements were condensed or omitted as permitted by such rules and regulations. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These interim condensed financial statements should be read in conjunction with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/26172/000002617221000012/cmi-20201231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Report on Form 10-K for the year ended December 31, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our interim period financial results for the three month periods presented are not necessarily indicative of results to be expected for any other interim period or for the entire year. The year-end </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> data was derived from audited financial statements, but does not include all required annual disclosures.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts for prior year periods were reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates in Preparation of Financial Statements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of financial statements requires management to make estimates and assumptions that affect reported amounts presented and disclosed in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Significant estimates and assumptions in these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Condensed Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">require the exercise of judgment. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be different from these estimates.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reporting Period</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reporting period usually ends on the Sunday closest to the last day of the quarterly calendar period. The first quarters of 2021 and 2020 ended on April 4 and March 29, respectively. Our fiscal year ends on December 31, regardless of the day of the week on which December 31 falls.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-Average Diluted Shares Outstanding </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average diluted common shares outstanding exclude the anti-dilutive effect of certain stock options. The options excluded from diluted earnings per share were as follows: </span></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.000%"><tr><td style="width:1.0%"/><td style="width:41.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.679%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 4,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 29,<br/>2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options excluded</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234,188 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>
CY2021Q2 cmi Company Owned And Independent Distributor Locations Number
CompanyOwnedAndIndependentDistributorLocationsNumber
500 location
CY2021Q2 cmi Dealer Locations Number
DealerLocationsNumber
9000 location
CY2021Q2 cmi Countries And Territories Number
CountriesAndTerritoriesNumber
190 country
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2780 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1234188 shares
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
847000000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
152000000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
695000000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P10Y
CY2021Q2 us-gaap Contract With Customer Receivable Before Allowance For Credit Loss
ContractWithCustomerReceivableBeforeAllowanceForCreditLoss
153000000 USD
CY2020Q4 us-gaap Contract With Customer Receivable Before Allowance For Credit Loss
ContractWithCustomerReceivableBeforeAllowanceForCreditLoss
114000000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1601000000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1531000000 USD
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
154000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
112000000 USD
CY2021Q2 us-gaap Revenues
Revenues
6092000000 USD
CY2020Q1 us-gaap Revenues
Revenues
5011000000 USD
CY2021Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
35000000 USD
CY2020Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
34000000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
166000000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
129000000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1000000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1000000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1000000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1000000 USD
CY2021Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
388000000 USD
CY2021Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax
9000000 USD
CY2021Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
397000000 USD
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
451000000 USD
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax
10000000 USD
CY2020Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
461000000 USD
CY2021Q2 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
163000000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
53000000 USD
CY2021Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
44000000 USD
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
42000000 USD
CY2021Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
207000000 USD
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
95000000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2320000000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2216000000 USD
CY2021Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1585000000 USD
CY2020Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1346000000 USD
CY2021Q2 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
3905000000 USD
CY2020Q4 us-gaap Fifo Inventory Amount
FIFOInventoryAmount
3562000000 USD
CY2021Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
152000000 USD
CY2020Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
137000000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
3753000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
3425000000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
466000000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
438000000 USD
CY2021Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
462000000 USD
CY2020Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
508000000 USD
CY2021Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
439000000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
479000000 USD
CY2021Q2 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
38000000 USD
CY2020Q4 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
0 USD
CY2021Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
308000000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
308000000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1713000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1733000000 USD
CY2021Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
279000000 USD
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
242000000 USD
CY2021Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
242000000 USD
CY2020Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
256000000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125000000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
128000000 USD
CY2021Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
94000000 USD
CY2020Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
82000000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
381000000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
404000000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1121000000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1112000000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
343000000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
325000000 USD
CY2021Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
322000000 USD
CY2020Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
325000000 USD
CY2021Q2 us-gaap Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability
TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability
289000000 USD
CY2020Q4 us-gaap Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability
TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability
289000000 USD
CY2021Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
192000000 USD
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
203000000 USD
CY2021Q2 us-gaap Derivative Instruments And Hedges Liabilities Noncurrent
DerivativeInstrumentsAndHedgesLiabilitiesNoncurrent
0 USD
CY2020Q4 us-gaap Derivative Instruments And Hedges Liabilities Noncurrent
DerivativeInstrumentsAndHedgesLiabilitiesNoncurrent
41000000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
364000000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
365000000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1510000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1548000000 USD
CY2021Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
93000000 USD
CY2020Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
169000000 USD
CY2021Q2 us-gaap Commercial Paper
CommercialPaper
317000000 USD
CY2020Q4 us-gaap Commercial Paper
CommercialPaper
323000000 USD
CY2021Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3500000000 USD
CY2020Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1500000000 USD
CY2018Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2000000000.0 USD
CY2021Q2 us-gaap Commercial Paper
CommercialPaper
317000000 USD
CY2021Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3500000000 USD
CY2021Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
3200000000 USD
CY2021Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
146000000 USD
CY2020Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
132000000 USD
CY2021Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
71000000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
72000000 USD
CY2021Q2 us-gaap Interest Rate Fair Value Hedge Liability At Fair Value
InterestRateFairValueHedgeLiabilityAtFairValue
44000000 USD
CY2020Q4 us-gaap Interest Rate Fair Value Hedge Liability At Fair Value
InterestRateFairValueHedgeLiabilityAtFairValue
48000000 USD
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
89000000 USD
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
91000000 USD
CY2021Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
3681000000 USD
CY2020Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
3672000000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
61000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
62000000 USD
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3620000000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3610000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
51000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
57000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
534000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
30000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
506000000 USD
CY2021Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
500000000 USD
CY2021Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
4338000000 USD
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
4665000000 USD
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4091000000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4164000000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2307000000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2389000000 USD
CY2021Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
157000000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
97000000 USD
CY2021Q2 us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
65000000 USD
CY2020Q1 us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
66000000 USD
CY2021Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3000000 USD
CY2020Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2000000 USD
CY2021Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
146000000 USD
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
961000000 USD
CY2020Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
138000000 USD
CY2021Q2 us-gaap Extended Product Warranty Accrual Period Increase Decrease
ExtendedProductWarrantyAccrualPeriodIncreaseDecrease
-61000000 USD
CY2020Q1 us-gaap Extended Product Warranty Accrual Period Increase Decrease
ExtendedProductWarrantyAccrualPeriodIncreaseDecrease
-57000000 USD
CY2021Q2 us-gaap Extended Product Warranty Accrual Preexisting Increase Decrease
ExtendedProductWarrantyAccrualPreexistingIncreaseDecrease
-44000000 USD
CY2020Q1 us-gaap Extended Product Warranty Accrual Preexisting Increase Decrease
ExtendedProductWarrantyAccrualPreexistingIncreaseDecrease
-15000000 USD
CY2021Q2 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-6000000 USD
CY2020Q1 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-12000000 USD
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2275000000 USD
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2332000000 USD
CY2021Q2 us-gaap Product Liability Contingency Third Party Recovery
ProductLiabilityContingencyThirdPartyRecovery
4000000 USD
CY2020Q1 us-gaap Product Liability Contingency Third Party Recovery
ProductLiabilityContingencyThirdPartyRecovery
9000000 USD
CY2021Q2 us-gaap Deferred Revenue
DeferredRevenue
960000000 USD
CY2021Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1315000000 USD
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1346000000 USD
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2275000000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2307000000 USD
us-gaap Product Liability Accrual Period Expense
ProductLiabilityAccrualPeriodExpense
410000000 USD
CY2020Q4 us-gaap Product Liability Accrual Period Expense
ProductLiabilityAccrualPeriodExpense
20000000 USD
us-gaap Product Liability Accrual Period Expense
ProductLiabilityAccrualPeriodExpense
430000000 USD
CY2021Q2 us-gaap Product Liability Contingency Accrual Present Value
ProductLiabilityContingencyAccrualPresentValue
129000000 USD
CY2021Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
31000000 USD
CY2021Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
74000000 USD
CY2021Q2 us-gaap Purchase Obligation
PurchaseObligation
39000000 USD
CY2021Q2 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
100000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
48000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
21000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
27000000 USD
CY2021Q2 cmi Segment Reporting Information Income Lossbefore Interest Expense Income Taxes Depreciation Amortizationand Noncontrollinginterests
SegmentReportingInformationIncomeLossbeforeInterestExpenseIncomeTaxesDepreciationAmortizationandNoncontrollinginterests
980000000 USD
CY2021Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-18000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-279000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-26000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-253000000 USD
CY2020Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-14000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-239000000 USD
CY2021Q2 us-gaap Revenues
Revenues
6092000000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
260000000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
166000000 USD
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
6000000 USD
CY2021Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
169000000 USD
CY2020Q1 us-gaap Revenues
Revenues
5011000000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
238000000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
129000000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000000 USD
CY2020Q1 cmi Segment Reporting Information Income Lossbefore Interest Expense Income Taxes Depreciation Amortizationand Noncontrollinginterests
SegmentReportingInformationIncomeLossbeforeInterestExpenseIncomeTaxesDepreciationAmortizationandNoncontrollinginterests
846000000 USD
CY2020Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
168000000 USD
CY2021Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1000000 USD
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1000000 USD
CY2021Q2 cmi Segment Reporting Information Income Lossbefore Interest Expense Income Taxes Depreciation Amortizationand Noncontrollinginterests
SegmentReportingInformationIncomeLossbeforeInterestExpenseIncomeTaxesDepreciationAmortizationandNoncontrollinginterests
980000000 USD
CY2020Q1 cmi Segment Reporting Information Income Lossbefore Interest Expense Income Taxes Depreciation Amortizationand Noncontrollinginterests
SegmentReportingInformationIncomeLossbeforeInterestExpenseIncomeTaxesDepreciationAmortizationandNoncontrollinginterests
846000000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
28000000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
23000000 USD
CY2021Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
169000000 USD
CY2020Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
168000000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
783000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
655000000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
172000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
127000000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
611000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
528000000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17000000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
603000000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
511000000 USD

Files In Submission

Name View Source Status
0000026172-21-000027-index-headers.html Edgar Link pending
0000026172-21-000027-index.html Edgar Link pending
0000026172-21-000027.txt Edgar Link pending
0000026172-21-000027-xbrl.zip Edgar Link pending
cmi-20210404.htm Edgar Link pending
cmi-20210404.xsd Edgar Link pending
cmi-20210404_cal.xml Edgar Link unprocessable
cmi-20210404_def.xml Edgar Link unprocessable
cmi-20210404_g1.jpg Edgar Link pending
cmi-20210404_htm.xml Edgar Link completed
cmi-20210404_lab.xml Edgar Link unprocessable
cmi-20210404_pre.xml Edgar Link unprocessable
cmi2021q110-qex10a.htm Edgar Link pending
cmi2021q110-qex10b.htm Edgar Link pending
cmi2021q110-qex31a.htm Edgar Link pending
cmi2021q110-qex31b.htm Edgar Link pending
cmi2021q110-qex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending